ESC Congress 2013

31 August - 04 September 2013, Amsterdam - The Netherlands

Session Details

Poster Session 5: Diabetes: treatment and clinical implications
Mon 02 Sep 14:00 - 18:00 Diabetes, dysglycaemia and metabolic syndrome Poster Session Posters - Village 9

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00P4251Differences in mortality and cardiovascular risk associated with insulin in combination with individual insulin secretagogues or metformin - a nationwide studyUlrik Madvig MOGENSEN (Copenhagen, DK)
14:00P4252Diabetes is an independent risk factor for peripheral vascular disease but does not influence risk when coronary artery disease is verified among patients undergoing CAG - a nationwide studySadaf KAMIL (Hellerup, DK)
14:00P4253Effect of preoperative diabetic treatment on long-term cardiovascular outcomes in diabetic patients undergoing coronary revascularization therapy.Natsuhiko EHARA (Kobe, JP)
14:00P4254Prevention of left ventricular remodeling in type-2 diabetes patients with the ARB olmesartan: ECG-LVH results from the ROADMAP-studyRoland SCHMIEDER (Erlangen, DE)
14:00P4255Clinical impact on target achievement and complications of intensified glucose control on top of metformin: sulfonylurea and insulin vs. incretin-based treatment in clinical practicePeter BRAMLAGE (Mahlow, DE)
14:00P4256Oscillation of blood sugar and the occurrence of cardiovascular events in coronary artery disease with diabetes mellitusToshinobu SAITO (Shimotsuke-Shi, JP)
14:00P4257Association of metabolic syndrome with coronary artery remodeling of culprit plaque in patients with or without acute coronary syndrome: an intravascular ultrasound studyJae-Youn MOON (Seongnam, KR)
14:00P4258The clinical feature of the acute myocardial infarction patients with admission hyperglycemiaToru TAKII (Sendai, JP)
14:00P4259Analysis for tight control of hyperglycemia with basal-bolus regimen in diabetic patients with acute coronary syndromeJuan Jose PARRA FUERTES (Madrid, ES)
14:00P4260Relationship between preprocedual serum 1,5-anhydroglucitol concentrations and restenosis after implantation of drug-eluting stent.Junko ITO (Tokyo, JP)
14:00P4261Functional capacity after cardiac rehabilitation in diabetic vs non diabetic cardiac patients.Alfio STUTO (Siracusa, IT)
14:00P4262Relationship between diabetes, race, obesity and outcomes in patients with acute coronary syndrome: a pool analysis from randomized trialsMasaya KOSHIZAKA (Durham, US)
14:00P4263Predictive value of high-sensitivity troponin-I for adverse cardiovascular outcomes in patients with type 2 diabetes mellitusKai Hang YIU (Hong Kong, HK)
14:00P4264Achievement of ESC targets for cardiovascular risk factors among French diabetic patientsVanina BONGARD (Toulouse, FR)
14:00P4265Glucose fluctuations increase inducibility of atrial fibrillation in diabetic ratsShotaro SAITO (Yufu-City, JP)